BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.
Sorbi C, Belluti S, Atene CG, Marocchi F, Linciano P, Roy N, Paradiso E, Casarini L, Ronsisvalle S, Zanocco-Marani T, Brasili L, Lanfrancone L, Imbriano C, Di Rocco G, Franchini S.
Sorbi C, et al. Among authors: lanfrancone l.
Int J Mol Sci. 2023 Jun 2;24(11):9684. doi: 10.3390/ijms24119684.
Int J Mol Sci. 2023.
PMID: 37298633
Free PMC article.